Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials

Background: While long-acting injectable antipsychotics (LAIs) are hoped to reduce high relapse rates in schizophrenia, recent randomized controlled trials (RCTs) challenged the benefits of LAIs over oral antipsychotics (OAPs). Methods: Systematic review/meta-analysis of RCTs that lasted ≥6 months c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kishimoto, Taishiro, Robenzadeh, Alfred, Leucht, Claudia, Leucht, Stefan, Watanabe, Koichiro, Mimura, Masaru, Borenstein, Michael, Kane, John M., Correll, Christoph U.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3885289/
https://ncbi.nlm.nih.gov/pubmed/23256986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbs150
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi